INTRODUCTION
The genetics of cancer penetrance is an evolving field that is leading to new strategies for cancer prevention and treatment. Susceptibility loci can influence not only cancer incidence and metastasis, but also the penetrance of other genetic disorders as well as susceptibility to infectious diseases (1-2, www.informatics.jax.org). The penetrance of tumor phenotypes results from the interaction between genetics and environment. The variability of environmental factors and the genetic heterogeneity in human populations complicates the search for susceptibility loci. To control these factors, inbred mouse strains are useful models to search for allelic variants that confer susceptibility or resistance to different types of tumors (3) . Quantitative trait loci (QTLs) analyses in mice have already identified chromosomal regions involved in cancer (3) (4) (5) , and several proteincoding genes have a proven role as cancer susceptibility loci (6) (7) (8) (9) (10) . We suggest that a newly discovered family of noncoding genes, the miRNAs, could be responsible for susceptibility to solid tumors.
Several papers have shown that miRNAs play an important role in different cancers, including B cell chronic lymphocytic leukemias (11) , Burkitts lymphoma, colon cancer, lung cancer, and breast cancer (12) (13) (14) . Furthermore, miRNA expression profiles can be used to classify human solid tumors and leukemias (10, 15) . Some miRNAs can downregulate large numbers of target mRNAs (16) , and it is estimated that miRNAs could regulate 33% of the human genome (17) . These targets may be oncogenes and tumor suppressor genes, supporting the idea that miRNAs could influence susceptibility and predispose individuals to different cancers. Because miRNAs are responsible for fine regulation of gene expression, "tuning" cellular phenotypes during delicate processes like development and differentiation, they represent a family of candidate genes for cancer susceptibility.
Here, we evaluate the correlation of miRNAs with cancer susceptibility loci and identify miRNAs with a distinct pattern of flanking DNA regions in inbred mouse strains with diverse tumor phenotypes. Our work supports the hypothesis that miRNAs could represent a new family of susceptibility genes affecting the risk of cancer.
RESULTS AND DISCUSSION
A genome-wide approach was used to investigate associations between miRNAs and mouse cancer susceptibility loci. This type of investigation was previously successful in identifying a significant association between the genomic position of human miRNAs and that of fragile sites (FRAs) and cancer-associated genomic regions (CAGRs) (18) .
Compilation of known tumor susceptibility and modifier loci. We constructed a database that contained both susceptibility and modifier loci for 8 types of solid tumors in the mouse: bladder, colon, liver, lung, mammary gland, ovary, small intestine, and skin. The list was built by locus symbol, peak marker, chromosome (Chr), tissue, and strains. To obtain loci positions, we used the Mouse Genome
Informatics Database (www.informatics.jax.org) and PubMed (www.pubmed.gov).
Published data were evaluated to identify the peak location of each region (Fig. 1) .
Several observations were derived from this analysis. First, Chr 4 had the largest number of susceptibility loci (13 total), followed by Chr 6 (12 loci). Second, Chr Y had no susceptibility loci, followed by Chr 14 (1 locus). The frequency distribution (Fig. 4 , published as supporting information on the PNAS website) differs from a normal distribution, suggesting that genes predisposing to solid tumors are not distributed randomly within the genome, but tend to be concentrated on certain chromosomes. Third, Figure 1 shows that several susceptibility loci identified for the same organ overlap (such as for lung, Pas6 and Sluc2 on Chr 2, Pas1b and Sluc3 To test hypotheses about the relationship of the incidence of miRNAs and their association with tumor susceptibility loci, we used the Random Effect Poisson
Regression Model (18) . For this analyses, the random effect used was chromosome, in that data within a chromosome is assumed correlated. Under this model, the number of miRNAs defined "events" and non-overlapping lengths of susceptibility regions defined "time". The "length" of a susceptibility region was ±0.5 Mb if the gene is known, or estimated as ±5 Mb from the peak marker. Although a QTL need not be at the peak marker, the critical distance selected here covers the most likely interval.
A miRNA was considered within a susceptibility region if it was located ±5 Mb from the peak location of a given locus. The fixed effect in the model consisted of an indicator variable for the presence/absence of each susceptibility region. We report the incidence rate ratio (IRR), 2-sided 95% confidence interval of the incidence rate ratio, and 2-sided p-values for testing the hypothesis that the incident rate ratio is 1.0. An IRR significantly >1 indicates an increase in the number of miRNAs within a region. All statistical computations were completed using STATA v7.0.
Overall, 96 miRNAs (41.9%) were located <5 Mb from the peak of the closest locus (or loci), representing a highly significant association between the incidence of miRNAs and tumor susceptibility regions. Specifically, the relative incidence of miRNAs occurred at a rate 1.5 times higher in susceptibility regions than nonsusceptibility regions (IRR=1.63, 95% CI {1.25, 2.14}, p<0.001). Therefore, miRNAs
were found more often in (or near) susceptibility regions than in other areas of the genome (Fig. 2) . The estimated rate of miRNAs is moderate in most chromosomes, but quite large in Chrs 2, 6, 7, 13, and especially Chr 12. Thus, a larger number of miRNAs than expected by chance occurs in these 5 chromosomes. Regardless of location, the model indicates that miRNAs are significantly more likely to reside within tumor susceptibility regions than outside them. In addition, a recent report suggests an association between the locations of mouse miRNAs and known sites of retroviral integration in mouse cancers (21) . In addition, mir-181b-2 and mir-199b are 3.3 Mb from the peak of the colon Scc2 locus on Chr 2; homologous human miRNAs are located inside a CAGR at Chr 9q33-34.1, which is a region commonly deleted in bladder cancer (18) .
Some miRNAs can act as oncogenes or tumor suppressor genes (12, 14) . If our hypothesis that miRNAs are candidates for tumor susceptibility genes is true, it is expected that some miRNAs will act cell autonomously and be abnormally expressed in cancer cells, whereas others will act non-cell autonomously to influence cancer development (4). The expression of human homologs of candidate miRNAs for mouse tumor susceptibility loci was extensively reported. Nineteen of the 35 (54.3%) miRNAs located <2 Mb from the peak of a tumor susceptibility locus are abnormally expressed in at least one type of human solid cancer, with expression being significantly different from normal controls (19) (20) . Studies to discriminate differences in expression of candidate miRNAs between tumor susceptible and resistant strains are underway in our laboratories.
Direct sequence screen of inbred strains. Discrete sequence alterations are frequently found in human cancers (21) and variation in the sequence of precursor miRNAs were identified in the normal human population (24) and in the germline of cancer patients (25) . It was shown that a C to A polymorphism in the mature mir30c-2 sequence may alter target selection and thus exert profound biological effects (24) . According to the miRanda algorithm, 10 of 12 predicted targets were not considered likely for the A-type variant mir-30c-2. Interestingly, the mouse homolog is located <1 Mb from the peak marker of the lung Lscc1 locus on Chr 1.
We sequenced several miRNAs to determine if inbred strains with different tumor susceptibilities possessed unique alleles. Out of 229 miRNAs, 10% are located <1 Mb from the peak marker that defines 15 solid tumor susceptibility loci (see Table 1 as an example). In fact, 8 of these loci have >1 miRNA that lie within <1 Mb of their peak. Selection of miRNAs was based on criteria that included their proximity to susceptibility loci, the same miRNA being present in human CAGRs, and the available inbred strains. We sequenced 13 miRNAs (mir- Genomic regions corresponding to each precursor miRNA were amplified including flanking 5' and 3' ends, because these regions are needed for miRNA expression (26) . A highly conserved motif ~200 bp upstream of the miRNA stemloop was found in most independently (intergenic) transcribed nematode miRNAs (27) . Moreover, independent transcription units in which the precursor miRNA is sufficient for processing have been found in plants, with their promoter elements being located upstream of the stem-loop (28) .
Seven of the 13 miRNAs showed sequence differences between inbred strains (Figs. 3 and 5-8 , published as supporting information on the PNAS website). spretus has the only substitution found within a stem-loop structure.
For mir-30c-2 (near Lscc1), the resistant AKR and B6 strains had different alleles with 6 substitutions and one insertion-deletion (in-del). The susceptible A/J strain has a third allele (Fig. 5) . For mir-133a-2 (near Sluc17), a deletion of TATATGTA was found in the susceptible O20 compared to the resistant B10.O20 strain. Furthermore, there are four substitutions upstream and two substitutions downstream of the mir-133a-2 stem-loop (Fig. 6) . For mir-34a (near Mom6), 6
substitutions and one in-del was found between the susceptible B6 and the resistant AKR strains. AKR and C3H had the same allele, B6, BALB and A/J had a second allele, and CAST had a third allele (Fig. 7) . For mir-10a (near Par1/Pas5a), an in-del upstream of the stem-loop was detected in the susceptible A/J compared to the resistant B6 and SM/J strains (as well as BALB). M. spretus and CAST had additional unique alleles (Fig. 8) .
Computational prediction of miRNA promoters: Since only a few miRNA promoters have been identified experimentally (30-32), we used an automated computational pipeline to determine miRNA promoters, depending on their relative genomic location to the annotated protein-coding genes. The annotation system combines the genomic alignments of mRNAs and miRNAs with ab initio pol II promoter predictions of FirstEF (33) . The genomic sequences and alignments of RefSeq mRNAs and known mRNAs were downloaded from the UCSC website (genome.ucsc.edu). Genomic alignments of miRNAs were determined by the BLAT program (34).
For intragenic miRNAs that overlap with protein-coding genes and in the sense strand, the promoter of the host protein coding gene is considered as the promoter of the miRNA, since the 'host' transcript and miRNAs usually portray similar expression profiles indicating that these miRNAs are transcribed as part of long host transcription units (35) (36) (37) . For the rest, we ran the FirstEF program on the Table 3 , published as supporting information on the PNAS website).
Of 7 miRNAs that showed sequence differences between tumor susceptible and resistant strains, 5 miRNAs had changes within their predicted promoter regions ( Fig. 3 and Table 3 Sequencing: High-molecular weight kidney DNA was isolated using the Qiagen DNeasy Tissue Kit (Valencia, CA). The genomic region of each miRNA was amplified and sequenced using primers listed in Table 2 (published as supporting information on the PNAS website). Sequence analyses were performed on genomic DNA from two mice from each strain. 
